TWI PHARMACEUTICAL INC

Company Introduction: TWI PHARMACEUTICAL INC.

TWI PHARMACEUTICAL INC. is a company based in Taiwan.

It is a Manufacturer.

Detailed Information:

TWI Pharmaceutical Inc. is primarily engaged in the research, development, manufacturing, and sales of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company also functions as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services from process development to commercial manufacturing for various pharmaceutical products. Their operations involve significant production capabilities and facilities, confirming their role as a manufacturing entity within the pharmaceutical industry.

TWI Pharmaceutical Inc. manufactures and sells the following products:

Marketed Product:

Pledris (Gabapentin extended-release tablets) for Postherpetic Neuralgia.

Pipeline Products (in various stages of development):

Pain Management:

TWI-030 (Gabapentin extended-release tablets for Osteoarthritis Pain)

TWI-031 (Gabapentin extended-release tablets for Osteoarthritis Pain)

TWI-032 (Gabapentin extended-release tablets for Postherpetic Neuralgia)

TWI-035 (Non-opioid pain medication)

TWI-038 (Non-opioid pain medication)

Oncology Supportive Care:

TWI-020 (Oral Mucositis)

TWI-021 (Chemotherapy-Induced Nausea and Vomiting)

TWI-022 (Chemotherapy-Induced Diarrhea)

TWI-023 (Chemotherapy-Induced Peripheral Neuropathy)

TWI-025 (Cancer Cachexia)

TWI-026 (Immunotherapy-Related Adverse Events)